Showing results (71-80 of 330) with videos related to
Sort By:
Pageof 33
Journal of Psychiatric Research|January 1, 1988
The evaluation of 4-hydroxy-3-methoxyphenylglycol sulfate as a possible marker of central norepinephrine turnover. Studies in healthy volunteers and depressed patientsJ G Filser, J Spira, M Fischer, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|November 5, 2008
Conditioning training and retrieval increase phospholipase A(2) activity in the cerebral cortex of ratsE L Schaeffer, L Zorrón Pu, D A M Gagliotti, et al.Fortschritte Der Neurologie-Psychiatrie|November 13, 2001
[Antipsychotics and phospholipid metabolism in schizophrenia]A Schmitt, A Maras, D F Braus, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|November 22, 2001
Effects of antipsychotic treatment on membrane phospholipid metabolism in schizophreniaA Schmitt, A Maras, G Petroianu, et al.Dementia and Geriatric Cognitive Disorders|June 27, 2000
Cholesterol modulates the membrane-disordering effects of beta-amyloid peptides in the hippocampus: specific changes in Alzheimer's diseaseG P Eckert, N J Cairns, A Maras, et al.Biological Psychiatry|September 15, 1990
Increased serum phospholipase A2 activity in schizophrenia: a replication studyW F Gattaz, C V Hübner, T J Nevalainen, et al.Dementia (Basel, Switzerland)|July 1, 1996
Cortical NMDA receptor properties and membrane fluidity are altered in Alzheimer's diseaseK Scheuer, A Maras, W F Gattaz, et al.Pharmacopsychiatry|May 20, 1999
Diurnal variability of orofacial dyskinetic movementsE Baca-Garcia, J K Stanilla, C Büchel, et al.European Archives of Psychiatry and Clinical Neuroscience|January 1, 1996
Decreased phospholipase A2 activity in the brain and in platelets of patients with Alzheimer's diseaseW F Gattaz, N J Cairns, R Levy, et al.Experimental Gerontology|April 18, 2000
The effect of rivastigmine on sleep in elderly healthy subjectsM Schredl, B Weber, D Braus, et al.Pageof 33